Skip to main content
. 2015 Apr;22(2):e124–e127. doi: 10.3747/co.22.2283

FIGURE 1.

FIGURE 1

Alterations in the lipid composition of sebum in all patients during therapy with epidermal growth factor receptor inhibitor (egfri). Before administration of egfri, and at 2 weeks and 6 weeks after administration, sebum-absorbing sheets were used to collect sebum from the face and chest of treated patients. High-performance liquid chromatography was then used to determine the proportion of each lipid in the sebum.